Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Horizon Therapeutics < Previous 1 2 3 4 5 6 7 8 9 10 Next > 3 Stocks to Buy Low Today With High Hopes for Tomorrow April 15, 2024 Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns. Via InvestorPlace Peering Into Horizon Therapeutics's Recent Short Interest October 05, 2023 Via Benzinga Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today October 04, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 28, 2023 Via Benzinga How Is The Market Feeling About Horizon Therapeutics? September 18, 2023 Via Benzinga These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts September 13, 2023 During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... Via Benzinga $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today September 12, 2023 Via Benzinga Here's How Much $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today September 04, 2023 Via Benzinga The 3 Most Undervalued Biotech Stocks to Buy in September 2023 September 12, 2023 While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session September 11, 2023 Via Benzinga Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations September 05, 2023 On Friday, the U.S. Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 05, 2023 Via Benzinga This Is What Whales Are Betting On Horizon Therapeutics September 01, 2023 Via Benzinga Peering Into Horizon Therapeutics's Recent Short Interest August 31, 2023 Via Benzinga P/E Ratio Insights for Horizon Therapeutics August 30, 2023 Via Benzinga Is Amgen Stock a Top Buy and Hold? August 21, 2023 The biotech checks several important boxes for long-term shareholders. Via The Motley Fool Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review September 01, 2023 Tesla unveiled an updated Model 3, but also slashed Model S, X prices. Via Investor's Business Daily Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal September 01, 2023 The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc (NASDAQ: HZNP). Via Benzinga Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage September 01, 2023 The deal can now close in the fourth quarter. Via Investor's Business Daily Is This the Green Light Biotech Stocks Have Been Waiting For? August 31, 2023 It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics. Via The Motley Fool Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies' August 29, 2023 Via Benzinga Topics Stocks Exposures US Equities Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories August 28, 2023 Reuters Via Benzinga US Stocks Seen Opening Firmer In New Week's 1st Session As Traders Look To Week's Key Data; Analyst Constructive Despite Bearish Signals August 28, 2023 Via Benzinga FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal August 26, 2023 The Federal Trade Commission (FTC) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc (NASDAQ: AMGN), concerning its proposed acquisition of Horizon Therapeutics PLC... Via Benzinga Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle August 25, 2023 The FTC is pulling back somewhat on its effort to challenge the deal. Via Investor's Business Daily Could Amgen Stock Help You Become a Millionaire? August 16, 2023 Its pending acquisition of Horizon Therapeutics could make the company much bigger. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 07, 2023 Via Benzinga Amgen Beats Expectations, Raises Outlook With Horizon Takeover In The Wings August 03, 2023 The massive biotech company also beat second-quarter expectations Thursday. Via Investor's Business Daily Amgen To Report Q2 Earnings: Here's What To Expect July 31, 2023 Amgen will report second-quarter 2023 results on Aug. 3, after the market close. Via Talk Markets Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated July 28, 2023 Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.